Literature DB >> 21270093

Renal injury in angiotensin II+L-NAME-induced hypertensive rats is independent of elevated blood pressure.

Aaron J Polichnowski1, Limin Lu, Allen W Cowley.   

Abstract

The balance between angiotensin II (ANG II) and nitric oxide plays an important role in renal function and is thought to contribute to the progression of renal injury in experimental hypertension. In the present study, we investigated the extent of blood pressure (BP)-dependent and BP-independent pathways of renal injury following 2 wk of hypertension produced by intravenous infusion of ANG II (5 ng·kg⁻¹·min⁻¹)+N(ω)-nitro-l-arginine methyl ester (l-NAME; 1.4 μg·kg⁻¹·min⁻¹) in male Sprague-Dawley rats. An aortic balloon occluder was positioned between the renal arteries to maintain (24 h/day) BP to the left kidney (servo-controlled) at baseline levels, whereas the right kidney (uncontrolled) was chronically exposed to elevated BP. Over the 14-day experimental protocol, the average BP to uncontrolled kidneys (152.7 ± 1.8 mmHg) was significantly elevated compared with servo-controlled (113.0 ± 0.2 mmHg) kidneys and kidneys from sham rats (108.3 ± 0.1 mmHg). ANG II+l-NAME infusion led to renal injury that was focal in nature and mainly confined to the outer medulla. Despite the differences in BP between servo-controlled and uncontrolled kidneys, there was a similar ~3.5-fold increase in renal outer medullary tubular injury, ~2-fold increase in outer medullary interstitial fibrosis, ~2-fold increase in outer medullary macrophage infiltration, and a significant increase in renal oxidative stress, all of which are indicative of BP-independent mediated pathways. The results of this study have important implications regarding the pathogenesis of renal injury in various experimental models of hypertension and provide novel insights regarding the variable association observed between hypertension and renal injury in some human populations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270093      PMCID: PMC3074995          DOI: 10.1152/ajprenal.00354.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  49 in total

Review 1.  Hypothesis: the role of acquired tubulointerstitial disease in the pathogenesis of salt-dependent hypertension.

Authors:  R J Johnson; G F Schreiner
Journal:  Kidney Int       Date:  1997-11       Impact factor: 10.612

Review 2.  Role of the renal medulla in volume and arterial pressure regulation.

Authors:  A W Cowley
Journal:  Am J Physiol       Date:  1997-07

3.  Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha.

Authors:  C G Schnackenberg; C S Wilcox
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

4.  Basal nitric oxide production curtails arteriolar vasoconstrictor responses to ANG II in rat kidney.

Authors:  H Ikenaga; R W Fallet; P K Carmines
Journal:  Am J Physiol       Date:  1996-08

5.  Role of nitric oxide in short-term and prolonged effects of angiotensin II on renal hemodynamics.

Authors:  X Deng; W J Welch; C S Wilcox
Journal:  Hypertension       Date:  1996-05       Impact factor: 10.190

6.  The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.

Authors:  H M Siragy; R M Carey
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

7.  Relationship between renal perfusion pressure and blood flow in different regions of the kidney.

Authors:  D L Mattson; S Lu; R J Roman; A W Cowley
Journal:  Am J Physiol       Date:  1993-03

8.  Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation.

Authors:  A P Zou; F Wu; A W Cowley
Journal:  Hypertension       Date:  1998-01       Impact factor: 10.190

9.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

Authors:  R De Caterina; P Libby; H B Peng; V J Thannickal; T B Rajavashisth; M A Gimbrone; W S Shin; J K Liao
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

10.  Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.

Authors:  W G Walker; J D Neaton; J A Cutler; R Neuwirth; J D Cohen
Journal:  JAMA       Date:  1992-12-02       Impact factor: 56.272

View more
  13 in total

1.  Early life stress induces renal dysfunction in adult male rats but not female rats.

Authors:  Analia S Loria; Tatsuo Yamamoto; David M Pollock; Jennifer S Pollock
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-11-21       Impact factor: 3.619

Review 2.  Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents.

Authors:  Kafait U Malik; Brett L Jennings; Fariborz A Yaghini; Seyhan Sahan-Firat; Chi Young Song; Anne M Estes; Xiao R Fang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-12-20       Impact factor: 3.072

3.  Increased Perfusion Pressure Drives Renal T-Cell Infiltration in the Dahl Salt-Sensitive Rat.

Authors:  Louise C Evans; Galina Petrova; Theresa Kurth; Chun Yang; John D Bukowy; David L Mattson; Allen W Cowley
Journal:  Hypertension       Date:  2017-07-10       Impact factor: 10.190

4.  Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice.

Authors:  Brett L Jennings; Larry J Anderson; Anne M Estes; Fariborz A Yaghini; Xiao R Fang; Jason Porter; Frank J Gonzalez; William B Campbell; Kafait U Malik
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

5.  Involvement of cytochrome P-450 1B1 in renal dysfunction, injury, and inflammation associated with angiotensin II-induced hypertension in rats.

Authors:  Brett L Jennings; Larry J Anderson; Anne M Estes; Xiao R Fang; Chi Young Song; William B Campbell; Kafait U Malik
Journal:  Am J Physiol Renal Physiol       Date:  2011-11-16

6.  Increased susceptibility to kidney injury by transfer of genomic segment from SHR onto Dahl S genetic background.

Authors:  Kevin R Regner; Ashlyn C Harmon; Jan M Williams; Cary Stelloh; Ashley C Johnson; Patrick B Kyle; Alexandra Lerch-Gaggl; Sarah M White; Michael R Garrett
Journal:  Physiol Genomics       Date:  2012-05-01       Impact factor: 3.107

7.  Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein.

Authors:  Marcela Herrera; Matthew A Sparks; Adolfo R Alfonso-Pecchio; Lisa M Harrison-Bernard; Thomas M Coffman
Journal:  Hypertension       Date:  2012-11-12       Impact factor: 10.190

8.  Renal Perfusion Pressure Determines Infiltration of Leukocytes in the Kidney of Rats With Angiotensin II-Induced Hypertension.

Authors:  Satoshi Shimada; Justine M Abais-Battad; Ammar J Alsheikh; Chun Yang; Megan Stumpf; Theresa Kurth; David L Mattson; Allen W Cowley
Journal:  Hypertension       Date:  2020-08-03       Impact factor: 10.190

Review 9.  The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.

Authors:  Steven D Crowley
Journal:  Antioxid Redox Signal       Date:  2013-04-19       Impact factor: 8.401

10.  Transcriptomic analysis reveals inflammatory and metabolic pathways that are regulated by renal perfusion pressure in the outer medulla of Dahl-S rats.

Authors:  Louise C Evans; Alex Dayton; Chun Yang; Pengyuan Liu; Theresa Kurth; Kwang Woo Ahn; Steve Komas; Francesco C Stingo; Purushottam W Laud; Marina Vannucci; Mingyu Liang; Allen W Cowley
Journal:  Physiol Genomics       Date:  2018-03-30       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.